Phoenix Financial Ltd.

Position in BMY — Bristol Myers Squibb Co

CIK 1679543 Givatayim, L3

Position in BMY

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$6,583,314

-$346,191 QoQ

Shares Held

114,254

0.0% QoQ

Ownership

0.006%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

#478

of 2,506 holders

Holding Since

Mar 2020

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Phoenix Financial Ltd. holds $174,300,668 across 10 Drug Manufacturers - General names. BMY ranks #6 (3.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	97,019	$116,367,508
2	ABBV	AbbVie Inc.	47,441	$11,938,053
3	JNJ	Johnson & Johnson	46,830	$11,893,414
4	NVO	Novo Nordisk A S	158,343	$7,590,962
5	MRK	Merck & Co., Inc.	52,551	$6,752,803
6	BMY	Bristol Myers Squibb Co This page	114,254	$6,583,314
7	PFE	Pfizer Inc	253,976	$6,115,741
8	AZN	Astrazeneca PLC	19,365	$3,671,991

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,583,314	114,254	0.0%	Shares	Sole	2026-08-11
2026-03-31	$6,929,505	114,254	0.0%	Shares	Sole	2026-05-11
2025-12-31	$6,162,860	114,254	+7.6%	Shares	Sole	2026-02-05
2025-09-30	$4,787,544	106,154	+110.1%	Shares	Sole	2025-11-13
2025-06-30	$2,339,033	50,530	+330.4%	Shares	Defined	2025-07-30
2024-06-30	$487,561	11,740	-78.3%	Shares	Sole	2024-08-12
2024-03-31	$2,931,782	54,062	+1026.3%	Shares	Defined	2024-05-15
2023-12-31	$246,288	4,800	-79.5%	Shares	Defined	2024-02-14
2023-09-30	$1,358,136	23,400	-44.3%	Shares	Defined	2023-12-04
2023-06-30	$2,685,900	42,000	+121.2%	Shares	Defined	2023-08-07
2022-03-31	$1,386,620	18,987	-16.4%	Shares	Sole	2022-05-10
2020-12-31	$1,408,763	22,711	-78.0%	Shares	Sole	2021-02-11
2020-09-30	$6,219,757	103,164	-33.3%	Shares	Sole	2020-11-10
2020-06-30	$9,096,124	154,696	+286.5%	Shares	Sole	2020-08-10
2020-03-31	$2,231,160	40,028	—	Shares	Sole	2020-05-20
No filing history on record for this holder in this stock.